Highlights 1 for the year ended 31 March 2009 on an Investment basis unless noted otherwise Operational profit from the portfolio of 20.4m, a 35% increase on the prior year 2008: 15.1m Loss before tax of 22.0m due to a 42.4m capital loss resulting from lower valuations within the portfolio Total expense ratio for the Group of 1.74% 2008: 1.85% Net operational cashflow of 23.4m, representing 1.26 times cover for the distributions paid in the year Second interim dividend of 3.275p for six months to 31 March 2009 declared on 20 May 2009, giving total dividend of 6.4p for the year, a growth of 2.4% with a scrip dividend alternative Directors Valuation of the portfolio at 31 March 2009 of 445.7m, up from 2 437.9m at 31 March 2008, a 1.8% increase Net asset value NAV per share post dividend of 107.2p at 31 March 2009, in line with guidance given in January NAV per share at 31 March 2009 of 110.5p on an Investment basis and 111.1p on a consolidated IFRS basis Investments in the year of 51.2m including a 50% stake in the Oxford John Radcliffe Hospital 1.
In order to provide shareholders with further information regarding the Groups net asset value, coupled with greater transparency in the Companys capacity for investment and ability to make distributions, as in previous periods, the results have been restated in proforma tables with all investments accounted for on an Investment basis.
The Directors Valuation of 437.9m at 31 March 2008 reconciles to the value of 417.4m in the Investment basis financial statements since it includes 20.5m of unfunded loan stock commitments.
